Current position:Home >Product >
2-Pyridineacetamide, N-[3-(6-amino-3-pyridazinyl)-2-propyn-1-yl]-N-(4-fluorophenyl)-3,5-bis(trifluoromethyl)-
2-Pyridineacetamide, N-[3-(6-amino-3-pyridazinyl)-2-propyn-1-yl]-N-(4-fluorophenyl)-3,5-bis(trifluoromethyl)-(2832047-80-8)
- Name: 2-Pyridineacetamide, N-[3-(6-amino-3-pyridazinyl)-2-propyn-1-yl]-N-(4-fluorophenyl)-3,5-bis(trifluoromethyl)-
- Synonyms:2-Pyridineacetamide, N-[3-(6-amino-3-pyridazinyl)-2-propyn-1-yl]-N-(4-fluorophenyl)-3,5-bis(trifluoromethyl)-;N-(3-(6-Aminopyridazin-3-yl)prop-2-yn-1-yl)-2-(3,5-bis(trifluoromethyl)pyridin-2-yl)-N-(4-fluorophenyl)acetamide;RP-6685, 10 mM in DMSO;N-[3-(6-aminopyridazin-3-yl)prop-2-yn-1-yl]-2-[3,5-bis(trifluoromethyl)pyridin-2-yl]-N-(4-fluorophenyl)acetamide - [AC78316];RP-6685;N-[3-(6-Amino-3-pyridazinyl)-2-propyn-1-yl]-N-(4-fluorophenyl)-3,5-bis(trifluoromethyl)-2-pyridineacetamide
- Molecular Formula:C22H14F7N5O
- Molecular Weight:497.37
- CAS Registry Number:2832047-80-8
- EINECS:
- Melting Point:599.1±50.0 °C(Predicted)
- Water Solubility:
Other Product
- 283164-79-4/2,5-Cyclohexadien-1-one, 2,6-dichloro-4-[(4-hydroxyphenyl)imino]-, sodium salt, hydrate (1:1:1)
- 283167-84-0/1,?3-?Dioxolane, 2-?methyl-?2-?[1-?[(1Z)?-?1-?methyl-?4-?(trimethylsilyl)?-?1-?buten-?3-?yn-?1-?yl]?cyclopropyl]?-
- 283167-85-1/Ethanone, 1-?[1-?[(1Z)?-?1-?methyl-?4-?(trimethylsilyl)?-?1-?buten-?3-?yn-?1-?yl]?cyclopropyl]?-
- 283167-98-6/Ethanone, 1-?[1-?[(1R,?2R)?-?1,?2-?dihydroxy-?1-?methyl-?4-?(trimethylsilyl)?-?3-?butyn-?1-?yl]?cyclopropyl]?-
- 283170-47-8/3-(Benzyloxy)-5-bromobenzaldehyde
- 283170-62-7/N1-(2-furylmethyl)-2,6-dimethylpiperidine-1-carbothioamide
- 283170-81-0/4-Thiazolemethanol, 2-[(2,6-dimethylphenyl)amino]-4,5-dihydro-4-methyl-
- 283171-79-9/4-methyl-6-pyridin-2-ylsulfanylpyrimidin-2-amine
- 2831740-61-3/Ethyl (3R,4R,5R)-4-Hydroxy-3-isopropoxy-5-((methylsulfonyl)oxy)cyclohex-1-ene-1-carboxylate
- 28317-54-6/Butanenitrile, 2-[2-[3,5-bis(trifluoromethyl)phenyl]hydrazinylidene]-3-oxo-
- 28317-62-6/Butanenitrile, 2-[2-(3,5-dichlorophenyl)hydrazinylidene]-3-oxo-
- 28317-63-7/Butanenitrile, 3-oxo-2-[2-(2,4,5-trichlorophenyl)hydrazinylidene]-
- 28317-64-8/Butanenitrile, 2-[2-(4-chloro-2-methylphenyl)hydrazinylidene]-3-oxo-
- 28317-65-9/Butanenitrile, 2-[2-[4-chloro-2-(trifluoromethyl)phenyl]hydrazinylidene]-3-oxo-
- 28317-71-7/Butanenitrile, 2-[2-(2,4-dinitrophenyl)hydrazinylidene]-3-oxo-
- 28317-77-3/Butanenitrile, 2-[2-[2-(ethylsulfonyl)-5-(trifluoromethyl)phenyl]hydrazinylidene]-3-oxo-
- 28317-78-4/Butanenitrile, 3-oxo-2-[2-[4-[(trifluoromethyl)thio]phenyl]hydrazinylidene]-
- 28317-93-3/Pentanenitrile, 2-[2-(3,4-dichlorophenyl)hydrazinylidene]-4,4-dimethyl-3-oxo-
- 2831861-00-6/4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-8-nitro-
- 2832047-80-8/2-Pyridineacetamide, N-[3-(6-amino-3-pyridazinyl)-2-propyn-1-yl]-N-(4-fluorophenyl)-3,5-bis(trifluoromethyl)-
- 2832061-33-1/9,12-Octadecadienoic acid, 1,1′-(1,4-piperazinediyldi-2,1-ethanediyl) ester, (9E,9′E,12E,12′E)-
- 2832083-17-5/(2-(methyl((1-(methyl(3-(((methylglycyl)oxy)methyl)pyridin-2-yl)amino)ethoxy)carbonyl)amino)pyridin-3-yl)methyl methylglycinate
- 2832100-74-8/Lifitegrast Impurity 2
- 2832108-21-9/2-(4-fluorophenyl)propan-2-yl 4-vinylbenzoate
- 2832127-60-1/Lifitegrast Impurity 1
- 2832128-82-0/6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine-2-methanol, 7,8,9,10-tetrahydro-
- 2832162-01-1/Benzoic acid, 2-chloro-4-[[2-(diethylamino)ethyl]amino]-, 2-(diethylamino)ethyl ester
- 2832230-34-7/[(1R)-3-Oxocyclopentyl]methyl ethanesulfonate
- 2832230-69-8/[(1S)-3-Oxocyclopentyl]methyl ethanesulfonate
- 2832231-52-2/1-Pyrrolidinecarboxylic acid, 3-ethyl-4-hydroxy-, 1,1-dimethylethyl ester, (3R,4R)-rel-